Acceleron Pharma
XLRN
#1557
Rank
โ‚ฌ10.55 B
Marketcap
172,57ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,833.42%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.1 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ0.10 Billion. In 2020 the company made a revenue of โ‚ฌ89.32 Million an increase over the revenue in the year 2019 that were of โ‚ฌ71.43 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.1 M6.47%
2020โ‚ฌ89.32 M25.05%
2019โ‚ฌ71.43 M428.85%
2018โ‚ฌ13.5 M3.78%
2017โ‚ฌ13.01 M-51.45%
2016โ‚ฌ26.8 M53.47%
2015โ‚ฌ17.46 M23.68%
2014โ‚ฌ14.12 M-74.43%
2013โ‚ฌ55.24 M275.17%
2012โ‚ฌ14.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ31.40 B 28,751.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.36 B 12,179.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ84.66 B 77,669.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.21 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.48 M-53.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.28 M-52.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.03 B 53,206.91%๐Ÿ‡บ๐Ÿ‡ธ USA